Literature DB >> 28567397

Poor outcome reporting in medical research; building practice on spoilt grounds.

Styliani Mantziari1, Nicolas Demartines1.   

Abstract

Year:  2017        PMID： 28567397      PMCID： PMC5440299          DOI： 10.21037/atm.2017.03.75

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  14 in total

1.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

2.  Registration of observational studies: is it time?

Authors:  Rebecca J Williams; Tony Tse; William R Harlan; Deborah A Zarin
Journal:  CMAJ       Date:  2010-07-19       Impact factor: 8.262

3.  Underreporting of Secondary Endpoints in Randomized Trials: Cross-sectional, Observational Study.

Authors:  Jacob H Matthews; Shivam Bhanderi; Stephen J Chapman; Dmitri Nepogodiev; Thomas Pinkney; Aneel Bhangu
Journal:  Ann Surg       Date:  2016-12       Impact factor: 12.969

4.  Publication and non-publication of clinical trials: longitudinal study of applications submitted to a research ethics committee.

Authors:  Erik von Elm; Alexandra Röllin; Anette Blümle; Karin Huwiler; Mark Witschi; Matthias Egger
Journal:  Swiss Med Wkly       Date:  2008-04-05       Impact factor: 2.193

5.  The levels of evidence and their role in evidence-based medicine.

Authors:  Patricia B Burns; Rod J Rohrich; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2011-07       Impact factor: 4.730

6.  Reducing waste from incomplete or unusable reports of biomedical research.

Authors:  Paul Glasziou; Douglas G Altman; Patrick Bossuyt; Isabelle Boutron; Mike Clarke; Steven Julious; Susan Michie; David Moher; Elizabeth Wager
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

7.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors:  Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  BMJ       Date:  2015-01-02

8.  Developing core outcome sets for clinical trials: issues to consider.

Authors:  Paula R Williamson; Douglas G Altman; Jane M Blazeby; Mike Clarke; Declan Devane; Elizabeth Gargon; Peter Tugwell
Journal:  Trials       Date:  2012-08-06       Impact factor: 2.279

9.  COS-STAR: a reporting guideline for studies developing core outcome sets (protocol).

Authors:  Jamie J Kirkham; Sarah Gorst; Douglas G Altman; Jane Blazeby; Mike Clarke; Declan Devane; Elizabeth Gargon; Paula R Williamson
Journal:  Trials       Date:  2015-08-22       Impact factor: 2.279

Review 10.  Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review.

Authors:  Kerry Dwan; Carrol Gamble; Paula R Williamson; Jamie J Kirkham
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240
View more
  5 in total

Review 1.  Outcome reporting recommendations for clinical trial protocols and reports: a scoping review.

Authors:  Nancy J Butcher; Emma J Mew; Andrea Monsour; An-Wen Chan; David Moher; Martin Offringa
Journal:  Trials       Date:  2020-07-08       Impact factor: 2.279

2.  Primary outcome reporting in adolescent depression clinical trials needs standardization.

Authors:  Andrea Monsour; Emma J Mew; Sagar Patel; Alyssandra Chee-A-Tow; Leena Saeed; Lucia Santos; Darren B Courtney; Priya N Watson; Suneeta Monga; Peter Szatmari; Martin Offringa; Nancy J Butcher
Journal:  BMC Med Res Methodol       Date:  2020-05-25       Impact factor: 4.615

3.  Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).

Authors:  Nancy J Butcher; Andrea Monsour; Emma J Mew; Peter Szatmari; Agostino Pierro; Lauren E Kelly; Mufiza Farid-Kapadia; Alyssandra Chee-A-Tow; Leena Saeed; Suneeta Monga; Wendy Ungar; Caroline B Terwee; Sunita Vohra; Dean Fergusson; Lisa M Askie; Paula R Williamson; An-Wen Chan; David Moher; Martin Offringa
Journal:  Trials       Date:  2019-03-06       Impact factor: 2.279

Review 4.  Immunotherapy for Esophageal Cancer: State-of-the Art in 2021.

Authors:  Hugo Teixeira Farinha; Antonia Digklia; Dimitrios Schizas; Nicolas Demartines; Markus Schäfer; Styliani Mantziari
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

5.  Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials.

Authors:  Johannes Schneider-Thoma; Angelika Kapfhammer; Dongfang Wang; Irene Bighelli; Spyridon Siafis; Hui Wu; Wulf-Peter Hansen; John M Davis; Georgia Salanti; Stefan Leucht
Journal:  Syst Rev       Date:  2021-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.